drugset / Trial / NCT01016717
Clopidogrel Proton-Pump Inhibitors Study
RandomizedCrossoverDouble-blindTreatment
Summary
To find out the impact of two different proton-pump inhibitors (PPIs) (Omeprazole and Pantoprazole) on platelet function in patients with stable coronary artery disease (CAD) on clopidogrel therapy.
Timeline
- Start
- 2012-12
- Primary completion
- 2012-12
- Completion
- 2012-12
Outcome
Outcome not reported
Stopped: “Since the published data resolved the study goals we decided not to start it”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Omeprazole | Other / unclassified | 40 mg | — |
| Comparator | Pantoprazole | Other / unclassified | 40 mg | — |